跳转至内容
Merck
  • Transcatheter embolisation of type 1 endoleaks after endovascular aortic aneurysm repair with Onyx: when no other treatment option is feasible.

Transcatheter embolisation of type 1 endoleaks after endovascular aortic aneurysm repair with Onyx: when no other treatment option is feasible.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery (2013-01-02)
J-Y Chun, R Morgan
摘要

Type 1 endoleaks following endovascular aortic aneurysm repair are associated with poor outcomes and re-intervention is recommended as soon as possible after diagnosis. When standard endovascular or surgical treatment options are unsuitable due to severe co-morbidity or adverse anatomic factors, patients can be treated by transcatheter embolisation of the endoleak itself. We describe six such patients with proximal and distal type 1 endoleaks, who have been successfully treated by transcatheter embolisation with Onyx. The embolisation technique, advantages of using this relatively novel liquid embolic agent and potential pitfalls are discussed.

材料
货号
品牌
产品描述

Sigma-Aldrich
钽, powder, −325 mesh, 99.9% trace metals basis
Sigma-Aldrich
Sigma-Aldrich
钽, foil, thickness 0.025 mm, ≥99.9% trace metals basis
Sigma-Aldrich
钽, foil, thickness 0.25 mm, ≥99.9% trace metals basis
Sigma-Aldrich
钽, foil, thickness 0.05 mm, ≥99.9% trace metals basis
Sigma-Aldrich
钽, powder, 60-100 mesh, 99.9%
Sigma-Aldrich
钽, wire, diam. 1.0 mm, ≥99.9% trace metals basis
Sigma-Aldrich
钽, foil, thickness 0.5 mm, ≥99.9% trace metals basis
Sigma-Aldrich
钽, foil, thickness 1.0 mm, ≥99.9% trace metals basis